Recurrence patterns in patients with low-grade intermediate-risk non-muscle invasive bladder cancer eligible for active surveillance
Paolo Zaurito,
Pietro Scilipoti,
Mattia Longoni
et al.
Abstract:Objective
The intermediate-risk non-muscle invasive bladder cancer (IR-NMIBC) prognostic group is heterogeneous. Growing evidence supports the role of active surveillance (AS) for patients with low-risk NMIBC, however, no clear data exists considering IR-NMIBC.
Methods
We retrospectively evaluated 174 LG IR-NMIBC patients who underwent transurethral resection of bladder tumor (TURBT) from 2012 to 2023 at a tertiary referral center and fulfilled the inclusion criteria for enrollment in AS protocols at the in… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.